Risk Capital Partners buys majority stake in Xstrahl

Risk Capital Partners acquired a majority stake in Xstrahl, a medical devices company that designs and manufactures X-ray systems for cancer treatment and research.

“Risk Capital Partners, today announces that it has bought a majority stake in Xstrahl, a medical devices business that designs and delivers effective clinical and research solutions to advance radiation oncology.”riskcapitalpartners.co.uk

• 2 sources
• riskcapitalpartners.co.ukRisk Capital Partners | Risk Capital Partners announces that it has bought a majority stake in Xstrahl | a different kind of private equity firmMar 12, 2018
• xstrahl.comRisk Capital Partners backs Xstrahl Buyout - XstrahlLauren ErlandsonApr 5, 2018

Summarized from public sources; check the original articles before acting on it.